Skip to content 
Oncocount is a useful tool for physicians and patients alike. The test detects the presence of Circulating Tumor Cells (CTCs) and quantifies The results from RGCC tests using CTC technology, including Oncocount, are not for diagnostic or health screening purposes. their concentration in the bloodstream, offering vital information. A higher number of CTCs might be associated with a greater spread of cancer.
How does Oncocount work?
- Oncocount detects the presence of CTCs and their concentration in the blood. It is used for monitoring and treatment efficacy purposes.
- Oncocount provides two crucial pieces of information: the presence of CTCs and their concentration.
How does Oncocount help?
- Follow-up tool to monitor the cancer disease burden.
- Assessment of cancer treatment response.
- Early warning test for relapse and recurrence
Test details
Sample type
Whole peripheral blood sample
Sample size
10-15 ml peripheral whole blood
Analysis period
Approx. 7 business days
Cancer type
Applicable for all cancer types
